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Regarding “Internal endoconduit: An innovative
technique to address unfavorable iliac artery
anatomy encountered during thoracic
endovascular aortic repair”
We read with great interest the article of Peterson and Mat-
sumura1 concerning an innovative technique to deal with unfavor-
able iliac artery anatomy during thoracic endovascular aortic repair
(TEVAR). This technique allows for the safe passage of large-
profile delivery sheaths during TEVAR by means of the deploy-
ment of an iliac stent graft, followed by angioplasty and controlled
rupture of the iliac artery. We have found this technique extremely
ingenious and simple, although we agree with the authors that a
larger series needs to be examined before any conclusions can be
made about the safety of this technique.
The authors report three patients free from complications
related to decreased pelvis perfusion or iliac artery hemorrhage.
One patient had an occluded hypogastric artery, and there are no
data relating to the permeability of this artery in the remainder. We
would like to know whether the authors consider the hypogastric
artery permeability a contraindication for performing this tech-
nique; and if not, should we consider the presence of back bleeding
from the hypogastric artery after the controlled rupture of the iliac
artery an irrelevant issue?
August Ysa, MD
Maite R. Bustabad, MD
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Reply
We are pleased that you are interested in our report on the
endoconduit.1 In the two subsequent cases mentioned in the case
report, the hypogastric arteries were patent, as they have been in
two out of three cases utilizing the endoconduit since submission
of the original manuscript. We understand your concern regarding
back-bleeding from a patent hypogastric artery using the endocon-
duit technique, but in our experience, the endoconduit alone
seems to prevent back-bleeding; and therefore, we do not consider
a patent hypogastric artery to be an absolute contraindication to
using an endoconduit. Similar findings have been reported in the
literature when one considers the absence of type II endoleak with
hypogastric artery orifice coverage without coil embolization
during the endovascular management of aortoiliac aneurysms.2
In our cases, the controlled ruptures have seemed to take place
in the mid-external iliac artery. However, if the area of stenosis
that mandates the use of an endoconduit is adjacent to the
hypogastric origin and rupture is anticipated in this area, a
preemptive strategy of embolizing the hypogastric main trunk
when it is patent could be useful to prevent back-bleeding. Once
again, we appreciate your interest in our article. We hope that
this technique helps you and others address unfavorable iliac
anatomy during aortic endovascular procedures, and we agree
that larger series are needed to draw definitive conclusions
regarding the safety of this technique.
Brian G. Peterson, MD
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Regarding “Endovascular repair of ruptured
abdominal aortic aneurysms”
A meta-analysis by Mastracci et al1 concluded that mortality in
patients undergoing endovascular repair of ruptured abdominal
aortic aneurysms was lower than that in historical reports of un-
selected patients undergoing open repair. Only the endovascular
repair arms (representing 436 patients) of the controlled compar-
isons reported, however, were summarized in the meta-analysis
because the authors hypothesized that control groups would be
variable in their composition and that many would be clearly
biased. In a previous meta-analysis by Visser et al (representing 608
patients: 204 in the endovascular repair group and 404 in the open
repair group),2 an odds ratio (OR) for mortality adjusted for
patients’ hemodynamic condition at presentation in the hospital
was calculated by performing a meta-regression analysis in which
they included the proportion of patients with low systolic blood
pressures in each treatment group as covariate in the regression
model. In another attempt to correct for and minimize selection
bias that exists in observational studies, we herein performed a
meta-analysis pooling not crude but adjusted ORs reported in
comparative studies of endovascular vs open repair of ruptured
abdominal aortic aneurysms.
Our comprehensive search identified four (two prospective3,4
and two retrospective5,6) observational studies reporting an ad-
justed OR and only one randomized controlled trial.7 Moore et al3
used a logistic regression model including systolic blood pressure,
absence of systolic blood pressure, and glomerular filtration rate.
In the study by Peppelenbosch et al,4 the factors for which adjust-
ment was made included advanced age, male gender, hemody-
namic shock (systolic tension 100 mm Hg), and a history of
pulmonary disease. Greco et al5 used multivariate logistic regres-
sion analysis in which the dichotomous covariates included were
procedure (open or endovascular); demographic variables of
age (younger or older than 65), gender, and race; and comor-
bidities (diabetes, hypertension, emphysema, coronary, periph-
eral vascular disease, renal, cerebral, and lipids). In the study by
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